Back to search

Article

Hematopoietic fitness of <i>JAK2<sup>V617F</sup></i> Myeloproliferative Neoplasms is linked to clinical outcome

2021-02-01

Abstract excerpt

Myeloproliferative Neoplasms (MPN) harbor highly recurrent driver mutations affecting targetable kinases yet treatment options for these phenotypically diverse diseases are limited, and patients experience significant morbidity and shortened survival. The most important disease-related complications—thrombosis, transformation and death—are not used as clinical trial endpoints due to the long follow-up required to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b1e38acb-8d67-5f2a-b842-73fe3249c90c
DOI
10.1101/2021.01.28.21250575
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Hematopoietic fitness of <i>JAK2<sup>V617F</sup></i> Myeloproliferative Neoplasms is linked to clinical outcomeDOI 10.1101/2021.01.28.21250575
Select a neighboring publication to make it the new centre.